Papers
1
Total Citations
10
H-Index
1
About
Dr. Jerry Kong is a urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer patients. His most impactful work centers on the critical debate between extended and standard pelvic lymph node dissection (PLND) during radical prostatectomy. In his landmark 2022 meta-analysis, which has garnered 10 citations, Dr. Kong systematically synthesized all available evidence to compare perioperative complications between the two PLND templates. This rigorous study provides essential data for surgeons weighing the staging benefits of extended dissection against its potential morbidity. Beyond this core contribution, Dr. Kong’s research addresses the delicate balance between oncologic control and surgical safety in genitourinary cancers. His work directly informs clinical decision-making, helping urologists tailor lymphadenectomy extent to individual patient risk profiles. By clarifying complication rates and surgical trade-offs, Dr. Kong has advanced evidence-based practice in prostate cancer surgery, making him a valuable voice in the ongoing effort to refine surgical staging while minimizing patient harm.
Research Focus
Key Achievements
Top Papers
- 1